Lab Overview: TPOAb (Thyroid Peroxidase Antibodies)

What is TPOAb?

Thyroid peroxidase antibodies (TPOAb) are immune proteins directed against thyroid peroxidase (TPO), an enzyme required for the production of thyroid hormones T4 and T3. When these antibodies are present, they signal immune activity against thyroid tissue. TPOAb is most commonly associated with Hashimoto’s thyroiditis, though it may also be detected in Graves’ disease and other autoimmune thyroid conditions.

TPO antibodies may be elevated even when TSH and thyroid hormone levels remain within laboratory reference ranges. In this setting, TPOAb can reflect early or subclinical autoimmune thyroid activity and may indicate increased risk for future thyroid dysfunction.

Why Test for TPOAb?

Evaluating TPO antibodies helps clinicians determine whether thyroid symptoms or abnormal thyroid labs have an autoimmune driver. TPOAb testing is commonly used to investigate:

• Subclinical hypothyroidism or borderline elevated TSH
• Fatigue, weight gain, cold intolerance, constipation, hair thinning, or brain fog
• Goiter or structural thyroid changes
• Fluctuating thyroid lab values
• Pregnancy planning or postpartum thyroid monitoring
• Family or personal history of autoimmune disease

Identifying autoimmune involvement can influence monitoring frequency, treatment thresholds, and long-term management strategy.

Clinical Significance of TPOAb Levels

• Low TPOAb Levels:  TPOAb levels below the laboratory reference cutoff (commonly <30–35 IU/mL, though some assays use lower thresholds such as <9 IU/mL) are considered negative and generally indicate no measurable autoimmune thyroid activity. A negative result suggests that thyroid dysfunction, if present, is less likely to be autoimmune in origin. That said, antibody levels can fluctuate over time, and early autoimmune processes may occasionally precede detectable antibody elevation. Clinical correlation and periodic reassessment may be appropriate if suspicion remains high. 
  
  
• High TPOAb Levels:  TPOAb levels at or above the laboratory cutoff (often ≥35 IU/mL, depending on assay) support the presence of autoimmune thyroiditis, most commonly Hashimoto’s disease. Higher antibody levels are associated with increased likelihood of progression from subclinical to overt hypothyroidism, particularly when TSH is elevated. Some individuals may have positive TPOAb with normal thyroid hormone levels; in these cases, antibodies reflect immune activity and future risk rather than immediate dysfunction. In pregnancy and postpartum settings, TPOAb positivity is associated with increased risk of thyroid instability and warrants closer thyroid monitoring. 

Actionable Insights

TPOAb should be interpreted in context rather than as an isolated value. Antibodies indicate immune activity, but they do not always correlate directly with symptom severity or immediate thyroid hormone disruption. A patient may have elevated antibodies with normal TSH and Free T4, while another may demonstrate gradual thyroid failure over time.

A TPOAb value within range does not guarantee long-term thyroid stability—autoimmune activity can evolve gradually, and antibody levels may rise before TSH shifts outside reference range. TPOAb is commonly evaluated alongside TSH, Free T4, Free T3, and sometimes thyroglobulin antibodies to assess overall thyroid immune status.

When abnormalities are identified, clinical focus often shifts to identifying upstream contributors such as genetic predisposition, immune dysregulation, micronutrient status (iron, selenium, vitamin D), gut health considerations, systemic inflammation, and hormonal shifts such as pregnancy or postpartum changes. Monitoring trends over time may provide greater insight than a one-time measurement.

Optimal Ranges

•  Negative — commonly <30–35 IU/mL, though some assays use <9 IU/mL 

Note: Reference ranges vary by laboratory. In functional medicine, some providers may consider a narrower interpretive window to help guide clinical context. These values are not standardized and should be interpreted in conjunction with the ordering provider’s judgment.

“For patients with TPOAb >120 IU/mL (especially if trending upward or >500 IU/mL), literature supports a heightened risk profile—accelerating annual conversion rates from 2-4% to 4-15% and cumulative 5-year risks up to 20-86% in high-aggressiveness cases. Early lifestyle interventions (e.g., selenium/vitamin D optimization, anti-inflammatory diet) alongside monitoring every 6-12 months to potentially halve progression rates and preserve thyroid function, even in euthyroid states.”

Dr. Mitch Ghen - Director of Physician Consultations, Access Labs 

Disclaimer: Content on the Access Medical Labs blog is for informational purposes only and reflects the views of individual contributors, not necessarily those of Access Medical Labs. We do not endorse specific treatments, products, or protocols. This content is not a substitute for professional medical advice. Always consult a qualified healthcare provider regarding any medical concerns.

About Access:

Access is the nation’s premier specialty diagnostic lab. We offer a broad menu of testing from blood, saliva, urine & swab samples. We perform all of your tests in our 25,000 sq. ft. ultra-automated facility in Jupiter, Florida & provide results within 24hrs. Since 2003, we continuously strive to innovate, inspire, and improve solutions for physicians by providing an exceptional personalized experience with the most accurate testing.

Feel free to contact our specialist to find out more about prices and services. We are always ready to answer your questions: sales@accessmedlab.com